This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Orally Disintegrating Tablet Market

Global Market Study on Orally Disintegrating Tablet: Convenience of usage to drive market expansion

Orally Disintegrating Tablet Market Segmented By Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensives, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitors Drug Class with CNS Diseases, GI Diseases, CVS Disorders, Allergy Disease Indication

- Table of Content -

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Dynamics

3.1. Macro-Economic Factors

3.2. Drivers

3.2.1. Supply Side Drivers

3.2.2. Demand Side Drivers

3.3. Restraints

3.4. Opportunities

3.5. Trends

4. Key Inclusion

4.1. Formulation processes for Orally Disintegrating Tablets

4.2. Value Chain Analysis

5.Global Orally Disintegrating Tablets MarketValue Analysis 2012-2021 and Forecast, 2022-2025

5.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2025

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Drug Class

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012-2021

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2022 - 2025

6.3.1. Anti-Psychotics

6.3.2. Anti-Epileptic’s

6.3.3. CNS Stimulants

6.3.4. Anxiolytics

6.3.5. Anti-Parkinson Ian Drugs

6.3.6. Anti-Hypertensives

6.3.7. NSAIDS

6.3.8. Anti-Allergy Drugs

6.3.9. Proton Pump Inhibitor

6.3.10. Others

6.4. Market Attractiveness Analysis By Drug Class

7. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Disease Indication

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2012-2021

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022 - 2025

7.3.1. Central Nervous System Diseases (CNS)

7.3.2. Gastrointestinal (GI) Diseases

7.3.3. Cardiovascular(CVS) Diseases

7.3.4. Allergy

7.3.5. Others

7.4. Market Attractiveness Analysis By Disease Indication

8. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2025

8.3.1. Hospital Pharmacy

8.3.2. Retail Pharmacy

8.3.3. Drug Stores

8.3.4. Online Pharmacy

8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2025

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia-Pacific

9.3.5. Middle East & Africa

9.4. Market Attractiveness Analysis By Region

10. North America Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Drug Class

10.3.3. By Disease Indication

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.5. Drivers & Restraints: Impact Analysis

10.6. Partial List of Players with Product Intensity Map By Country

11. Latin America Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025

11.3.1. By Country

11.3.1.1. Brazil

11.3.1.2. Mexico

11.3.1.3. Rest of Latin America

11.3.2. By Drug Class

11.3.3. By Disease Indication

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.5. Drivers & Restraints: Impact Analysis

11.6.部分玩家与产品Intensi列表ty Map By Country

12. Europe Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. U.K.

12.3.1.3. France

12.3.1.4. Italy

12.3.1.5. Spain

12.3.1.6. Russia

12.3.1.7. Rest of Europe

12.3.2. By Drug Class

12.3.3. By Disease Indication

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Drivers & Restraints: Impact Analysis

12.6. Partial List of Players with Product Intensity Map By Country

13. Asia-Pacific Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025

13.1. Introduction

13.2.历史市场规模(Mn)美元趋势分析is By Market Taxonomy, 2012-2021

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Japan

13.3.1.4. Australia & New Zealand

13.3.1.5. Rest of Asia-Pacific

13.3.2. By Drug Class

13.3.3. By Disease Indication

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Drivers & Restraints: Impact Analysis

13.6. Partial List of Players with Product Intensity Map By Country

14. Middle East and Africa Orally Disintegrating Tablets Market Analysis 2012-2021 and Forecast 2022-2025

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2021

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2025

14.3.1. By Country

14.3.1.1. GCC Countries

14.3.1.2. South Africa

14.3.1.3. Rest of MEA

14.3.2. By Drug Class

14.3.3. By Disease Indication

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Drivers & Restraints: Impact Analysis

14.6. Partial List of Players with Product Intensity Map By Country

15. Competition Analysis

15.1. Company Share Analysis

15.2. Market Structure by Tier of Companies

15.3. Competition Dashboard

15.4. Competition Deep Dive

15.4.1.Teva Pharmaceutical Industries Ltd.

15.4.1.1. Company Overview

15.4.1.2. Segment Overview

15.4.1.3. Product Offerings

15.4.1.4. Financial Analysis

15.4.1.5. Key Developments

15.4.1.6. Strategy Overview

15.4.2.Novartis AG

15.4.2.1. Company Overview

15.4.2.2. Segment Overview

15.4.2.3. Product Offerings

15.4.2.4. Financial Analysis

15.4.2.5. Key Developments

15.4.2.6. Strategy Overview

15.4.3.AstraZeneca

15.4.3.1. Company Overview

15.4.3.2. Segment Overview

15.4.3.3. Product Offerings

15.4.3.4. Financial Analysis

15.4.3.5. Key Developments

15.4.3.6. Strategy Overview

15.4.4.Mylan N.V.

15.4.4.1. Company Overview

15.4.4.2. Segment Overview

15.4.4.3. Product Offerings

15.4.4.4. Financial Analysis

15.4.4.5. Key Developments

15.4.4.6. Strategy Overview

15.4.5.Pfizer Inc.

15.4.5.1. Company Overview

15.4.5.2. Segment Overview

15.4.5.3. Product Offerings

15.4.5.4. Financial Analysis

15.4.5.5. Key Developments

15.4.5.6. Strategy Overview

15.4.6.Johnson & Johnson Services, Inc.

15.4.6.1. Company Overview

15.4.6.2. Segment Overview

15.4.6.3. Product Offerings

15.4.6.4. Financial Analysis

15.4.6.5. Key Developments

15.4.6.6. Strategy Overview

15.4.7.F. Hoffmann-La Roche Ltd.

15.4.7.1. Company Overview

15.4.7.2. Segment Overview

15.4.7.3. Product Offerings

15.4.7.4. Financial Analysis

15.4.7.5. Key Developments

15.4.7.6. Strategy Overview

15.4.8.Merck & Co., Inc.

15.4.8.1. Company Overview

15.4.8.2. Segment Overview

15.4.8.3. Product Offerings

15.4.8.4. Financial Analysis

15.4.8.5. Key Developments

15.4.8.6. Strategy Overview

15.4.9.Bausch Health

15.4.9.1. Company Overview

15.4.9.2. Segment Overview

15.4.9.3. Product Offerings

15.4.9.4. Financial Analysis

15.4.9.5. Key Developments

15.4.9.6. Strategy Overview

15.4.10.GlaxoSmithKline plc.

15.4.10.1. Company Overview

15.4.10.2. Segment Overview

15.4.10.3. Product Offerings

15.4.10.4. Financial Analysis

15.4.10.5. Key Developments

15.4.10.6. Strategy Overview

15.4.11.Sun Pharmaceutical Industries Ltd.

15.4.11.1. Company Overview

15.4.11.2. Segment Overview

15.4.11.3. Product Offerings

15.4.11.4. Financial Analysis

15.4.11.5. Key Developments

15.4.11.6. Strategy Overview

15.4.12.Bayer AG

15.4.12.1. Company Overview

15.4.12.2. Segment Overview

15.4.12.3. Product Offerings

15.4.12.4. Financial Analysis

15.4.12.5. Key Developments

15.4.12.6. Strategy Overview

15.4.13.Eli Lily and Company

15.4.13.1. Company Overview

15.4.13.2. Segment Overview

15.4.13.3. Product Offerings

15.4.13.4. Financial Analysis

15.4.13.5. Key Developments

15.4.13.6. Strategy Overview

15.4.14.Dr. Reddy’s Laboratories Ltd.

15.4.14.1. Company Overview

15.4.14.2. Segment Overview

15.4.14.3. Product Offerings

15.4.14.4. Financial Analysis

15.4.14.5. Key Developments

15.4.14.6. Strategy Overview

15.4.15.Takeda Pharmaceutical Company Limited

15.4.15.1. Company Overview

15.4.15.2. Segment Overview

15.4.15.3. Product Offerings

15.4.15.4. Financial Analysis

15.4.15.5. Key Developments

15.4.15.6. Strategy Overview

16. Assumptions and Acronyms Used

17. Research Methodology

Sample Report

FREEReport Sample is Available

In-depth report coverage is now just a few seconds away

Download PDFGet FREE Report Sample

- List Of Table -

Table 01: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class

Table 02: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication

Table 03: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel

Table 04: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Region

Table 05: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country

Table 06: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class

Table 07: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication

Table 08: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel

Table 09: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country

Table 10: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class

Table 11: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication

Table 12: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel

Table 13: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country

Table 14: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class

Table 15: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication

Table 16: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel

Table 17: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country

Table 18: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class

Table 19: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication

Table 20: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel

Table 21: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Country

Table 22: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Drug Class

Table 23: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Disease Indication

Table 24: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2025, By Distribution Channel

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 01: Global Orally Disintegrating Tablets Market Split By Drug Class (2022E)

Figure 02: Global Orally Disintegrating Tablets Market Split By Disease Indication (2022E)

Figure 03: Global Orally Disintegrating Tablets Market Split By Distribution Channel (2022E)

Figure 04: Global Orally Disintegrating Tablets Market Split By Region (2022E)

Figure 05: Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021

Figure 06: Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025

Figure 07: Orally Disintegrating Tablets Market Absolute $ Opportunity, 2022–2025

Figure 08: Orally Disintegrating Tablets Market Share Analysis (%), By Drug Class, 2022 & 2025

Figure 09: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Drug Class, 2022–2025

Figure 10: Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class, 2022–2025

Figure 11: Orally Disintegrating Tablets Market Share Analysis (%), By Disease Indication, 2022 & 2025

Figure 12: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Disease Indication, 2022–2025

Figure 13: Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025

Figure 14: Orally Disintegrating Tablets Market Share Analysis (%), By Distribution Channel, 2022 & 2025

Figure 15: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Distribution Channel, 2022–2025

Figure 16: Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025

Figure 17: Orally Disintegrating Tablets Market Share Analysis (%), By Region, 2022 & 2025

Figure 18: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Region, 2022–2025

Figure 19: Orally Disintegrating Tablets Market Attractiveness Analysis by Region, 2022–2025

Figure 20: North America Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)

图21:北美口头瓦解选项卡lets Market Value Share, Disease Indication, 2022 (E)

Figure 22: North America Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)

Figure 23: North America Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)

Figure 24: North America Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021

Figure 25: North America Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025

图26:北美口头瓦解选项卡lets Market Attractiveness Analysis by Drug Class, 2022–2025

Figure 27: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025

Figure 28: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025

Figure 29: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025

Figure 30: Latin America Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)

Figure 31: Latin America Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)

Figure 32: Latin America Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)

Figure 33: Latin America Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)

Figure 34: Latin America Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021

Figure 35: Latin America Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025

Figure 36: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025

Figure 37: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025

Figure 38: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025

Figure 39: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025

Figure 40: Europe Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)

Figure 41: Europe Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)

Figure 42: Europe Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)

Figure 43: Europe Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)

Figure 44: Europe Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021

Figure 45: Europe Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025

Figure 46: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025

Figure 47: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025

Figure 48: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025

Figure 49: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025

Figure 50: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)

Figure 51: Asia-Pacific Orally Disintegrating Tablets Market Value Share, Disease Indication, 2022 (E)

Figure 52: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)

Figure 53: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)

Figure 54: Asia-Pacific Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021

Figure 55: Asia-Pacific Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025

Figure 56: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2022–2025

Figure 57: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025

Figure 58: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2022–2025

Figure 59: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2022–2025

Figure 60: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Drug Class, 2022 (E)

图61:口服Disintegrat中东和非洲ing Tablets Market Value Share, Disease Indication, 2022 (E)

Figure 62: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2022 (E)

Figure 63: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Country, 2022 (E)

Figure 64: Middle East & Africa Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2012–2021

Figure 65: Middle East & Africa Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2022–2025

Figure 66: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class, 2022–2025

Figure 67: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2022–2025

Figure 68: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel, 2022–2025

Figure 69: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis, By Country, 2022–2025

Figure 70: Orally Disintegrating Tablets Market: Company Share Analysis Share Analysis (2022)

Google translate